Toronto Dominion Bank
CYTK icon

Toronto Dominion Bank’s Cytokinetics CYTK Stock Holding History

Toronto Dominion Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-180,800
Closed -$1.37M – 1022
2013
Q3 		$1.37M Buy
+180,800
New +$1.94M ﹤0.01% 268

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Toronto Dominion Bank's CYTK Position: Q1 2022 in Review

Toronto Dominion Bank sold out of Cytokinetics (CYTK) in Q1 2022, closing a stake of 50,644 shares — an estimated $2.31M sold.

Toronto Dominion Bank first reported a position in CYTK in Q4 2021 and held it in 1 quarter. The position peaked at $2.31M in Q4 2021. 240 funds tracked by Wall St. Rank hold CYTK as of Q1 2022.

  • Toronto Dominion Bank reported no remaining Cytokinetics position as of Q1 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 50,644 Cytokinetics shares in Q1 2022, an estimated $2.31M.
  • Toronto Dominion Bank first reported a position in Cytokinetics in Q4 2021 and held it in 1 quarter.
  • Toronto Dominion Bank's Cytokinetics position peaked at $2.31M in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2022.

Based on Toronto Dominion Bank's 13F filing for Q1 2022, filed 9 May 2022.